US.COR · Cencora

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.1947653025309575,
        "turnoverUsdM": 205.44065791,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.COR",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 292.5608,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.4,
      "take_profit_price": 328.1565,
      "target_multiplier": 1.6,
      "technical_strength": 1.22,
      "take_profit_percent": 5
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.389530605061915,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 62.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 61.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 313.9125,
    "ma50": 299.3198,
    "close": 312.53,
    "prevClose": 313.82,
    "avgVolume20": 1482307,
    "volumeRatio": 0.44,
    "changePercent": -0.41
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": -0.03836923076923082,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.435046790824498,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.857578580015925,
      "volat_points": 0,
      "day_range_pct": 0.021773941701596772,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 62.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 10,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 6.3,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 63,
        "contribution": 6.3
      },
      {
        "raw": 16.6,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 55.33,
        "contribution": 16.6
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 61.5,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 10/20分",
      "風險管理總分: 6.3/10分",
      "技術信號分析總分: 16.6/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 10,
      "基本面": 3.6,
      "資金流": 10.8,
      "市場環境": 10.2,
      "情緒分析": 4,
      "技術信號": 16.6,
      "風險管理": 6.3
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 10,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 2
            }
          },
          "catalystPoints": 10
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 205.44065791,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.COR",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.25
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 705.8159980000001,
                "ma50": 712.735402,
                "name": "QQQ",
                "close": 729.87,
                "points": 1.4
              },
              "spy": {
                "ma20": 757.7255032499999,
                "ma50": 749.238004,
                "name": "SPY",
                "close": 772.66998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.1947653025309575,
          "atrPoints": 2,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141223240,
                "url": "https://finnhub.io/api/news?id=6527909585ff50c3ffd622f59d25a2a8135b62bc5d4161ef630603722acb0040",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500’s -0.95%, 15.2%, and 9.98% […]",
                "category": "company",
                "datetime": 1786709161,
                "headline": "Cencora (COR): Leveraging Healthcare Growth and AI-Driven Productivity"
              },
              {
                "id": 141201944,
                "url": "https://finnhub.io/api/news?id=46f47e185eacdbfa38541a9505f664b5ebb5e17edeb61ab5dae921c3947a001d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Revenue hit $84.8 billion as GLP-1 sales surged 25% despite manufacturer price headwinds.",
                "category": "company",
                "datetime": 1786547685,
                "headline": "Cencora (COR) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 141127578,
                "url": "https://finnhub.io/api/news?id=7b6d8045c1e20e96c4e903337cbb6409651cbab146a7825d39267c1a9618e490",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora Inc (COR) delivered 17% adjusted operating income growth and raised its full-year EPS outlook, driven by robust specialty performance and strategic share repurchases.",
                "category": "company",
                "datetime": 1785963970,
                "headline": "Cencora Inc (COR) (Q3 2026) Earnings Call Highlights: Strong Double-Digit Growth and Raised Guidance"
              },
              {
                "id": 141124396,
                "url": "https://finnhub.io/api/news?id=ccc50ba97f5166d7f41c10bae16862c97183df302a52e0ed0d77d2f8bf699371",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora (NYSE:COR) has amended its credit and receivables facilities, including changes to its multi currency revolving credit facility and receivables securitization arrangements. The company has adjusted the size and maturity profile of its revolving credit facility and updated terms related to its receivables securitization structure. These financing changes are recent and represent material developments for Cencora’s capital structure and liquidity toolkit. Cencora operates as a major...",
                "category": "company",
                "datetime": 1785949866,
                "headline": "Cencora (COR) Expands Credit Facilities And Resets Receivables Terms"
              },
              {
                "id": 141126033,
                "url": "https://finnhub.io/api/news?id=61efde563bb79941be5878a0a9b2472f510923fbfb922d1e30dfd1eebefe2685",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "COR",
                "summary": "Cencora, Inc. (COR) Q3 2026 Earnings Call August 5, 2026 8:30 AM EDTCompany ParticipantsBennett Murphy - Senior VP Of Investor Relations & Enterprise...",
                "category": "company",
                "datetime": 1785945607,
                "headline": "Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 141122656,
                "url": "https://finnhub.io/api/news?id=026d8fb37247e734556ab139d7617d44722f4e154e1c54607e4041ad152a13a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 2026 outlook despite a slight revenue miss.",
                "category": "company",
                "datetime": 1785941400,
                "headline": "COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised"
              },
              {
                "id": 141122702,
                "url": "https://finnhub.io/api/news?id=649e57bb1b45b76b670239a97f3245a4c8aab937929935566ade37efc2991413",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
                "category": "company",
                "datetime": 1785936603,
                "headline": "Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 141121393,
                "url": "https://finnhub.io/api/news?id=5030e5ad46c6430658f4cf2676605baee23b9361856ffa7fc26ca6e3589201a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora (COR) delivered earnings and revenue surprises of +2.52% and -0.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785930303,
                "headline": "Cencora (COR) Surpasses Q3 Earnings Estimates"
              }
            ],
            "raw_source": [
              {
                "id": 141223241,
                "url": "https://finnhub.io/api/news?id=33a2434b268e9c2c0fa89571638f2150a7ee2e9c0b89bccb945d9e3a0e34de88",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.",
                "category": "company",
                "datetime": 1786736789,
                "headline": "AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141223240,
                "url": "https://finnhub.io/api/news?id=6527909585ff50c3ffd622f59d25a2a8135b62bc5d4161ef630603722acb0040",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500’s -0.95%, 15.2%, and 9.98% […]",
                "category": "company",
                "datetime": 1786709161,
                "headline": "Cencora (COR): Leveraging Healthcare Growth and AI-Driven Productivity"
              },
              {
                "id": 141215081,
                "url": "https://finnhub.io/api/news?id=46e1555335d1b3fb8660b90649ec0bdb67f2d339b6db31f86806d8269edc92c7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora’s second quarter was marked by performance that met Wall Street’s expectations on revenue and exceeded consensus on non-GAAP profitability, driving a positive market response. Management credited execution in specialty pharmaceuticals, especially through its Management Services Organizations (MSOs) like OneOncology and RCA, as a core driver of growth, while digital transformation initiatives improved operational efficiency. CEO Robert Mauch highlighted the company’s unique positioning in",
                "category": "company",
                "datetime": 1786690860,
                "headline": "5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call"
              },
              {
                "id": 141218551,
                "url": "https://finnhub.io/api/news?id=ae11daeda8d96877db82c0a10bfe918a675d25846e92a4e8064b2a6871c035f5",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of $59.16 billion.",
                "category": "company",
                "datetime": 1786639550,
                "headline": "If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today"
              },
              {
                "id": 141204220,
                "url": "https://finnhub.io/api/news?id=0d53e7cfc838cb3ace1409d01f73a7fdcde3e3ab900bbe384e3a289dc32023d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "The Morning Bull - US Market Morning Update Thursday, Aug, 13 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.2% and Nasdaq-100 futures ahead by roughly 0.6%, as investors focus on a key inflation update and what it could mean for interest rates. July CPI is expected at 3.4% year on year, with core inflation seen at 2.5%, which would suggest the cost of living is still rising but closer to the central bank’s comfort zone. At the same...",
                "category": "company",
                "datetime": 1786608546,
                "headline": "US Stock Market Today: S&P 500 Futures Edge Up As Traders Eye Key CPI"
              },
              {
                "id": 141201942,
                "url": "https://finnhub.io/api/news?id=87049698bf4459af6add0c1d50d42c36766ab980da8f92c3ffdc9fe68bb89f76",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "US equity indexes ended mixed Wednesday amid stock gains by some major technology stocks and a four-",
                "category": "company",
                "datetime": 1786565681,
                "headline": "US Equity Markets End Mixed Amid Tech Stock Gains, Lower Inflation Data"
              },
              {
                "id": 141200782,
                "url": "https://finnhub.io/api/news?id=3b5f954cd1b2c6018690020dd2e9080b368c3c279b3aaf21fa9af59eb700c847",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t",
                "category": "company",
                "datetime": 1786564721,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 141195030,
                "url": "https://finnhub.io/api/news?id=3a160a35b8171cc0055d79c795a9f5b630ffb9514f619fcf427e897552198643",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "COR",
                "summary": "Stay updated with the movements of the S&P500 index one hour before the close of the markets on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1786561501,
                "headline": "Uncover the latest developments among S&P500 stocks in today's session."
              },
              {
                "id": 141201944,
                "url": "https://finnhub.io/api/news?id=46f47e185eacdbfa38541a9505f664b5ebb5e17edeb61ab5dae921c3947a001d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Revenue hit $84.8 billion as GLP-1 sales surged 25% despite manufacturer price headwinds.",
                "category": "company",
                "datetime": 1786547685,
                "headline": "Cencora (COR) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 141193106,
                "url": "https://finnhub.io/api/news?id=108b6eb45cf4cc80a945dccddcb20e9433d76a346102b3bac10208632e8679ac",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "COR",
                "summary": "Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1786545301,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 141201945,
                "url": "https://finnhub.io/api/news?id=ff3b8e2fb99bc3cd66641392a6de719daceaefd5c4237f3b9f962600c6592bc1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.",
                "category": "company",
                "datetime": 1786544156,
                "headline": "Is Wall Street Bullish or Bearish on Cencora Stock?"
              },
              {
                "id": 141209844,
                "url": "https://finnhub.io/api/news?id=c25c7297158d160b395d0f672295014e5ac82e93cf063299e0ef2e825ea0f54b",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Beginning July 1, 2026, certain Walgreens volume that was being serviced by Cencora, Inc. (the "Company" or "Cencora") separate from the prime vendor agreement began moving outside the Company. The prime",
                "category": "company",
                "datetime": 1786538766,
                "headline": "Cencora Says Certain Walgreens Volume Moves Outside Cencora From July 1, 2026; Reaffirms FY26 Adj Diluted EPS Guidance Range Of $17.75-$17.95; Says Prime Vendor Agreement With Walgreens Remains Unchanged"
              },
              {
                "id": 141192693,
                "url": "https://finnhub.io/api/news?id=1a51c3fda625137f05bd7a8622dd3db9cd4f97aa3ff563d6f1aa5511d9562da4",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "COR",
                "summary": "As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.",
                "category": "company",
                "datetime": 1786538101,
                "headline": "Which S&P500 stocks are moving before the opening bell on Wednesday?"
              },
              {
                "id": 141200621,
                "url": "https://finnhub.io/api/news?id=a08e7c7fa18be82606ea2feeb7ddeeada1626fe5e95e301c926252196ccedab8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "AbbVie commands a premium valuation for its specialty drug pipeline, while CVS Health trades at a discount despite managing 37 million medical members.",
                "category": "company",
                "datetime": 1786481221,
                "headline": "AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141201490,
                "url": "https://finnhub.io/api/news?id=b27d87e3c8947f158bf4d832fe91f3e13a1b1c088d17bd7f1566ddeb622996ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "S&P 500 drug distributor Cardinal Health easily topped fiscal fourth-quarter earnings forecasts despite a revenue shortfall.  Rival McKesson, which whipsawed after its earnings report last week, has climbed back near a buy point.  Cencora, another big S&P 500 drug distributor, also is near a buy point, but MCK stock may be the strongest of the three.",
                "category": "company",
                "datetime": 1786454176,
                "headline": "S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results"
              },
              {
                "id": 141185958,
                "url": "https://finnhub.io/api/news?id=9dceabb509c6b4c2d44e38caac1aaa73c920b39d9457c65637e7ce654aa6d157",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Wells Fargo  analyst Stephen Baxter   maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $331 to $395.",
                "category": "company",
                "datetime": 1786438738,
                "headline": "Wells Fargo Maintains Overweight on Cencora, Raises Price Target to $395"
              },
              {
                "id": 141152474,
                "url": "https://finnhub.io/api/news?id=3852ba4223d6f6fd4381be34a82f8c1b6dd45b23181cf2e6ab311afb3d93f615",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "AbbVie generates stronger free cash flow and trades at a lower forward multiple, while Abbott offers diversification and a healthier balance sheet.",
                "category": "company",
                "datetime": 1786135497,
                "headline": "AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141151124,
                "url": "https://finnhub.io/api/news?id=d7465a2a4c88ee05863f3b79d5beec80125a4c5b3f1728075ee3ed1c26c3ad57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus as investors watch if growth offsets pricing headwinds.",
                "category": "company",
                "datetime": 1786126800,
                "headline": "Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?"
              },
              {
                "id": 141152423,
                "url": "https://finnhub.io/api/news?id=af72a397d825898b459a1a054ad11e152f22a3d67f610472c2aab599efe41d41",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "COR",
                "summary": "Weekly dividend activity roundup for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1786125278,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 9"
              },
              {
                "id": 141161487,
                "url": "https://finnhub.io/api/news?id=01551bf92cf6177580b86c7af2751e11be55f52b7ee7bc6186a2a8a67ec26af5",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Morgan Stanley  analyst Erin Wright    maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $342 to $346.",
                "category": "company",
                "datetime": 1786114644,
                "headline": "Morgan Stanley Maintains Overweight on Cencora, Raises Price Target to $346"
              },
              {
                "id": 141149837,
                "url": "https://finnhub.io/api/news?id=61a7ceb4ecf71a5ccab9c3c88be245268b077b60c02d70f829f7f2f67c7ffbe1",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "JP Morgan  analyst Lisa Gill   maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $382 to $390.",
                "category": "company",
                "datetime": 1786103269,
                "headline": "JP Morgan Maintains Overweight on Cencora, Raises Price Target to $390"
              },
              {
                "id": 141148551,
                "url": "https://finnhub.io/api/news?id=07d06119b1075744a6843489de2e699a01317cfa62b1b0dfc3eba4199b6cad1e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/07/Wall-Street-Bull.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Weak U.S. jobs data boosts hopes for a Fed pause, sending AI chip stocks and other high-beta tech names sharply higher. Here are 10 stocks to watch.",
                "category": "company",
                "datetime": 1786095456,
                "headline": "Terrible Jobs Report Sparks Rally In AI and Tech: 10 Stocks Leading Friday's Surge"
              },
              {
                "id": 141149839,
                "url": "https://finnhub.io/api/news?id=376df64bf3c7350fc547e69e8b33db5d6b1080aeac804bba959742c88077b769",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "UBS  analyst Kevin Caliendo   maintains Cencora (NYSE:COR) with a Buy and raises the price target from $412 to $430.",
                "category": "company",
                "datetime": 1786028754,
                "headline": "UBS Maintains Buy on Cencora, Raises Price Target to $430"
              },
              {
                "id": 141135645,
                "url": "https://finnhub.io/api/news?id=3dde5a2d60d99975caf75bc587fe9c7e63999fb47ed69b5880931abb1f14284b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "\"Not for distribution to United States news wire services or for dissemination in the United States.\" VANCOUVER, BC / ACCESS Newswire / August 6, 2026 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (\"Camino\" or the \"Company\") is pleased ...",
                "category": "company",
                "datetime": 1786014600,
                "headline": "Camino Announces $5.0 Million Brokered Private Placement of Units and Concurrent $9.5 Million Non-Brokered Private Placement of Convertible Debentures"
              },
              {
                "id": 141133359,
                "url": "https://finnhub.io/api/news?id=dd79fc4c3e385881a72f7ec44d829db3a1538bb7a6e10e38e6132fd8ff96feb5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora (NYSE:COR) reported fiscal 2026 third-quarter results marked by double-digit adjusted operating income growth, specialty-business momentum and $1 billion in share repurchases, prompting the pharmaceutical services company to raise its full-year adjusted earnings outlook. Adjusted operating",
                "category": "company",
                "datetime": 1786014253,
                "headline": "Cencora Q3 Earnings Call Highlights"
              },
              {
                "id": 141135225,
                "url": "https://finnhub.io/api/news?id=5a5c1b94de4ad35b775c69791623fcbe5431e41d94f05c65a8fbc479e3c47424",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Evercore ISI Group  analyst John Belton   maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $330 to $350.",
                "category": "company",
                "datetime": 1786013860,
                "headline": "Evercore ISI Group Maintains Outperform on Cencora, Raises Price Target to $350"
              },
              {
                "id": 141133573,
                "url": "https://finnhub.io/api/news?id=d3e790a365a65c1c6541e7aa0e79d403abf50c95684d2d8ec8a93eb29368f15d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2258773474/image_2258773474.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "COR",
                "summary": "Allspring Growth Fund outperformed the Russell 3000 Growth Index during the quarter. Read more here.",
                "category": "company",
                "datetime": 1786004100,
                "headline": "Allspring Growth Fund Q2 2026 Performance Update"
              },
              {
                "id": 141133360,
                "url": "https://finnhub.io/api/news?id=1c379f0456c61f6bb7b74e3cbcdb30629e1481c4297e8db99ae4cf816aabb253",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Moby summary of Cencora, Inc.'s Q3 2026 earnings call",
                "category": "company",
                "datetime": 1785985458,
                "headline": "Cencora, Inc. Q3 2026 Earnings Call Summary"
              },
              {
                "id": 141127578,
                "url": "https://finnhub.io/api/news?id=7b6d8045c1e20e96c4e903337cbb6409651cbab146a7825d39267c1a9618e490",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora Inc (COR) delivered 17% adjusted operating income growth and raised its full-year EPS outlook, driven by robust specialty performance and strategic share repurchases.",
                "category": "company",
                "datetime": 1785963970,
                "headline": "Cencora Inc (COR) (Q3 2026) Earnings Call Highlights: Strong Double-Digit Growth and Raised Guidance"
              },
              {
                "id": 141124396,
                "url": "https://finnhub.io/api/news?id=ccc50ba97f5166d7f41c10bae16862c97183df302a52e0ed0d77d2f8bf699371",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora (NYSE:COR) has amended its credit and receivables facilities, including changes to its multi currency revolving credit facility and receivables securitization arrangements. The company has adjusted the size and maturity profile of its revolving credit facility and updated terms related to its receivables securitization structure. These financing changes are recent and represent material developments for Cencora’s capital structure and liquidity toolkit. Cencora operates as a major...",
                "category": "company",
                "datetime": 1785949866,
                "headline": "Cencora (COR) Expands Credit Facilities And Resets Receivables Terms"
              },
              {
                "id": 141126033,
                "url": "https://finnhub.io/api/news?id=61efde563bb79941be5878a0a9b2472f510923fbfb922d1e30dfd1eebefe2685",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "COR",
                "summary": "Cencora, Inc. (COR) Q3 2026 Earnings Call August 5, 2026 8:30 AM EDTCompany ParticipantsBennett Murphy - Senior VP Of Investor Relations & Enterprise...",
                "category": "company",
                "datetime": 1785945607,
                "headline": "Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 141122656,
                "url": "https://finnhub.io/api/news?id=026d8fb37247e734556ab139d7617d44722f4e154e1c54607e4041ad152a13a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 2026 outlook despite a slight revenue miss.",
                "category": "company",
                "datetime": 1785941400,
                "headline": "COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised"
              },
              {
                "id": 141121867,
                "url": "https://finnhub.io/api/news?id=6beb908ae12813dfd98a52eb52bb2db4a5234cb5fae50594bf2bc304a6172d38",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "COR",
                "summary": "Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1785940501,
                "headline": "Which S&P500 stocks are gapping on Wednesday?"
              },
              {
                "id": 141122702,
                "url": "https://finnhub.io/api/news?id=649e57bb1b45b76b670239a97f3245a4c8aab937929935566ade37efc2991413",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
                "category": "company",
                "datetime": 1785936603,
                "headline": "Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 141123411,
                "url": "https://finnhub.io/api/news?id=a879ec48af6b7964732378061f2b128e265c342875780a7fbf7af85c00649e86",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "COR",
                "summary": "2026-08-05. The following slide deck was published by Cencora, Inc.",
                "category": "company",
                "datetime": 1785934885,
                "headline": "Cencora, Inc. 2026 Q3 - Results - Earnings Call Presentation"
              },
              {
                "id": 141121392,
                "url": "https://finnhub.io/api/news?id=d8fecbbba42d076c23b8142560b11a2890955927e943a6f833a130d41f3675e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora (NYSE:COR) reported third-quarter results that exceeded Wall Street expectations, prompting the pharmaceutical services company to raise its full-year earnings guidance. The stronger performance helped lift the shares more than 3% in pre-market trading.",
                "category": "company",
                "datetime": 1785934576,
                "headline": "Cencora raises full-year guidance after stronger-than-expected third-quarter results"
              },
              {
                "id": 141135227,
                "url": "https://finnhub.io/api/news?id=0447fd74b8529d7351be402d2713df61ca56aa007993e87b2431f88c67da21b3",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/Cencora-Photo-by-JHVEPhoto-via-Shutterst.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Cencora beats third-quarter earnings and revenue estimates, raised fiscal 2026 EPS guidance and maintains its annual sales forecast.",
                "category": "company",
                "datetime": 1785933873,
                "headline": "Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins"
              },
              {
                "id": 141121393,
                "url": "https://finnhub.io/api/news?id=5030e5ad46c6430658f4cf2676605baee23b9361856ffa7fc26ca6e3589201a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora (COR) delivered earnings and revenue surprises of +2.52% and -0.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785930303,
                "headline": "Cencora (COR) Surpasses Q3 Earnings Estimates"
              },
              {
                "id": 141120095,
                "url": "https://finnhub.io/api/news?id=f1cc2270c3224c5fe7b4fce9f3561f78a216695e2d4feb1950fb64f8b8afa8f9",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "COR",
                "summary": "Cencora (COR) Q3 EPS $4.48 beats, revenue $84.8B misses slightly; raises FY EPS guidance to $17.75-$17.95; shares +1.2% premarket.",
                "category": "company",
                "datetime": 1785929092,
                "headline": "Cencora (NYSE:COR) Shares Tick Up as Fiscal Q3 Results Meet Estimates, Full-Year Guidance Adjusted"
              },
              {
                "id": 141121394,
                "url": "https://finnhub.io/api/news?id=dc19cef70fb59cdec52bb21b732f0dd2bce8889a6946a1ceab52c26f4cc6f0ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAAP profit of $4.48 per share was 3% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785926639,
                "headline": "Cencora’s (NYSE:COR) Q2 CY2026 Earnings Results: Revenue In Line With Expectations"
              },
              {
                "id": 141120440,
                "url": "https://finnhub.io/api/news?id=d4cd7a8a21a50af7ea24b12278942178da446ee82f8031a8e5ccc198a1351e19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "CONSHOHOCKEN, Pa., August 05, 2026--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026 third quarter ended June 30, 2026, revenue increased 5.1 percent year-over-year to $84.8 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.94 for the third quarter of fiscal 2026 compared to $3.52 in the prior year third quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, incr",
                "category": "company",
                "datetime": 1785925800,
                "headline": "Cencora Reports Fiscal 2026 Third Quarter Results"
              },
              {
                "id": 141123039,
                "url": "https://finnhub.io/api/news?id=cb9ac40f56368cbb203d30ad410f52a37293956ceb4948692922270ce835990d",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 analyst estimate. Affirms FY2026 sales outlook from $334.152 billion-$340.578 billion to $334.152 billion-$340.578 billion",
                "category": "company",
                "datetime": 1785911488,
                "headline": "Cencora Raises FY2026 Adj EPS Guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 Est; Affirms FY2026 Sales Guidance of $334.152B-$340.578B vs $337.203B Est"
              },
              {
                "id": 141123040,
                "url": "https://finnhub.io/api/news?id=7eb4ddff6d1540572050369ee6dd980db3b6042ab4b5bf04708defb9254ece1e",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "Cencora (NYSE:COR) reported quarterly earnings of $4.48 per share which beat the analyst consensus estimate of $4.35 by 2.99 percent. This is a 12 percent increase over earnings of $4.00 per share from the same period",
                "category": "company",
                "datetime": 1785911428,
                "headline": "Cencora Q3 Adj. EPS $4.48 Beats $4.35 Estimate, Sales $84.754B Beat $84.315B Estimate"
              },
              {
                "id": 141114965,
                "url": "https://finnhub.io/api/news?id=a76269cd0057c2594211e58ca0d57d39fd42fa56d0cd555210da965d1354395d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.",
                "category": "company",
                "datetime": 1785870480,
                "headline": "What's in Store for These 4 Healthcare Companies This Earnings Season?"
              },
              {
                "id": 141111972,
                "url": "https://finnhub.io/api/news?id=df094ae2eec47696320d6e89f3712c0176396b232d54ecfe5bd52264caebb772",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak implants, while Wellspect growth offers support.",
                "category": "company",
                "datetime": 1785860520,
                "headline": "DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?"
              },
              {
                "id": 141123041,
                "url": "https://finnhub.io/api/news?id=2dbfa9ca5a07053410df0281921a5c825e0e84e4613ceeea5cd7d72199b11f9e",
                "image": "",
                "source": "Benzinga",
                "related": "COR",
                "summary": "https://www.bloomberg.com/news/articles/2026-08-04/ftc-takes-closer-look-at-merger-of-vet-products-distributors",
                "category": "company",
                "datetime": 1785851512,
                "headline": "'FTC Takes Closer Look at Merger of Vet Products Distributors' - Bloomberg"
              },
              {
                "id": 141103171,
                "url": "https://finnhub.io/api/news?id=2dd88a54341cf14e6baa4cffeea6d4819a7bc50413f219d15c0c28b9d506a609",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "COR's Q3 results could reflect specialty pharma strength, oncology expansion and margin gains, even as pricing dynamics and GLP-1 trends pressure revenues.",
                "category": "company",
                "datetime": 1785783420,
                "headline": "Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?"
              },
              {
                "id": 141103123,
                "url": "https://finnhub.io/api/news?id=956f1718fa4a9368b5b1e1c2d0314e3d2f1156a72ea5cdc41fba63ace48f774f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "McKesson heads into Q1 with AI-driven efficiency, specialty momentum and oncology growth in focus as pricing dynamics may temper revenues.",
                "category": "company",
                "datetime": 1785783300,
                "headline": "Can AI-Driven Efficiency and Specialty Demand Boost MCK's Q1 Results?"
              },
              {
                "id": 141101106,
                "url": "https://finnhub.io/api/news?id=5abe8d9ae172747fe7022fcdf4b95538561fe7641d2aa18259c89c9f3cac727a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "SOLV's Q2 results are likely to benefit from segment strength, Acera gains and cost savings, offset by tariffs and ERP-related sales timing shifts.",
                "category": "company",
                "datetime": 1785774960,
                "headline": "Solventum to Report Q2 Earnings: What's in Store for the Stock?"
              },
              {
                "id": 141081604,
                "url": "https://finnhub.io/api/news?id=410db8182804b6303abecfdda33650968aec0f21b03cd9a3d8bc4ae9c9c32635",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Globus Medical will report Q2 results on Aug. 6. Investors will be keen to know whether Enabling Technologies and Spine strength aid revenue & earnings growth.",
                "category": "company",
                "datetime": 1785518640,
                "headline": "GMED's Q2 Earnings on Deck: Will Enabling Technologies Lead Results?"
              },
              {
                "id": 141079152,
                "url": "https://finnhub.io/api/news?id=a808eb869fdbcfa2b4a80e6124eef78544a232043fe961454dad5c3f45670566",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter is available to download here. Mid-cap stocks delivered strong results, with the Russell Midcap® Growth Index rising 14.55% and slightly outperforming the Russell Midcap® Value Index’s 13.40% gain. Information […]",
                "category": "company",
                "datetime": 1785511823,
                "headline": "Cencora (COR) Remains Attractive Despite Temporary Headwinds"
              },
              {
                "id": 141079153,
                "url": "https://finnhub.io/api/news?id=21e0994149e81e949adbf3a5c3695d8481464e38dc5b5ede2c7132d7ec9f3bb3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Beyond analysts' top-and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785503702,
                "headline": "Countdown to Cencora (COR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS"
              },
              {
                "id": 141072995,
                "url": "https://finnhub.io/api/news?id=c0a17e245392d1ec49695d2ece10101db0da5d8315ebeeabf96e80a39de9c178",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Alignment Healthcare (ALHC) delivered earnings and revenue surprises of +30.77% and +1.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785446701,
                "headline": "Alignment Healthcare (ALHC) Beats Q2 Earnings and Revenue Estimates"
              },
              {
                "id": 141069852,
                "url": "https://finnhub.io/api/news?id=386a60c4175b7abbbd17001351c4bf87e46acc6e1264303741f9877b999c3b4a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "CRL is set to report Q2 results on Aug. 5 as investors watch segment demand, divestitures, and whether the company can extend its earnings beat streak.",
                "category": "company",
                "datetime": 1785432540,
                "headline": "Charles River Prepares to Report Q2 Earnings: What's in Store?"
              },
              {
                "id": 141068474,
                "url": "https://finnhub.io/api/news?id=0597a13729b6d9787ac42ddd83e5f452f49594e62235d6bb08b83ff253b36bb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "RVTY heads into Q2 earnings with improving Life Sciences demand and resilient Diagnostics. Can stronger margins offset lingering headwinds?",
                "category": "company",
                "datetime": 1785429600,
                "headline": "Revvity to Report Q2 Earnings: What's in Store for the Stock?"
              },
              {
                "id": 141066930,
                "url": "https://finnhub.io/api/news?id=518beb73f0fa8b074aedb034c03d8aa6974f1a54af460e6f1b7f62b2df2be2a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Concentra (CON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785420015,
                "headline": "Concentra Group (CON) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"
              },
              {
                "id": 141055914,
                "url": "https://finnhub.io/api/news?id=8bd971b273d56f21e3b50bf451fc2ae391fcc645537f4ec8c2962c18ae695476",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "CONSHOHOCKEN, Pa., July 29, 2026--Good Neighbor Pharmacy, a national franchise for independent pharmacies offered through Cencora, has been ranked \"#1 in Customer Satisfaction with Chain Drug Store Pharmacies\" in the JD Power 2026 U.S. Pharmacy StudySM, a syndicated benchmarking study profiling the experiences of customers of the largest pharmacies in the United States. In addition to ranking highest overall, Good Neighbor Pharmacy ranked highest across four of seven dimensions: Pharmacy offerin",
                "category": "company",
                "datetime": 1785346860,
                "headline": "Good Neighbor Pharmacy® Named #1 in Customer Satisfaction with Chain Drug Store Pharmacies and Most Trusted by JD Power"
              },
              {
                "id": 141054337,
                "url": "https://finnhub.io/api/news?id=70f30e8b833db3e67e4fe909db49118f6cb20473518649bf3bc78cd50e095b9d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785333620,
                "headline": "Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"
              },
              {
                "id": 141054225,
                "url": "https://finnhub.io/api/news?id=41aa526220e6ca239ab5014e1a1a76b5e395a007395bd137b135590ae8524e63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "ZBH heads into Q2 earnings with expectations of modest revenue growth as investors watch demand trends across knees, hips and robotics.",
                "category": "company",
                "datetime": 1785329880,
                "headline": "Zimmer Biomet Set to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 141045537,
                "url": "https://finnhub.io/api/news?id=cfbd5da4a6caa3910925d39710b35b7deaf6f8fdc595b085018fc0aeb1ebeed0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "BrightSpring heads into Q2 earnings with pharmacy and provider momentum, rising estimates and margin gains despite IRA and generic-conversion pressure.",
                "category": "company",
                "datetime": 1785255540,
                "headline": "Can Pharmacy Wins and Home-Based Care Boost BTSG's Q2 Results?"
              },
              {
                "id": 141043753,
                "url": "https://finnhub.io/api/news?id=26ad68828352e6c29c891a3dfad45b0b89d2bac7a4cc44630baee9cb00c94ea1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "HSIC heads into Q2 earnings with expectations for revenue and EPS growth as dental, specialty products and AI-enabled technology remain in focus.",
                "category": "company",
                "datetime": 1785245100,
                "headline": "Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 141033957,
                "url": "https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.",
                "category": "company",
                "datetime": 1785160469,
                "headline": "The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"
              },
              {
                "id": 141020312,
                "url": "https://finnhub.io/api/news?id=dc532c9bc04f7b5bc4e77ed03fe70f81a41e4f1cd5dfe97b80d03fea3bfc34f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Recent screening for stocks with rising P/E ratios and consistent price gains relative to the S&P 500 has put Cencora (COR) in focus for investors tracking valuation and earnings expectations. See our latest analysis for Cencora. Cencora’s recent screening attention comes after a generally mixed year for the share price, with a 30 day share price return of 8.94% contrasting with a year to date decline of 8.55% and a 1 year total shareholder return of 7.53%. This suggests longer term holders...",
                "category": "company",
                "datetime": 1785017518,
                "headline": "Is Cencora (COR) Still Trading At A Discount As Its P E Rerating Gains Pace?"
              },
              {
                "id": 141018634,
                "url": "https://finnhub.io/api/news?id=b60f47dabd99772e06676155e93c2a5955a8dfc5abad2a55c65481e3b6522c9f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Cencora stock has delivered a strong 167.1% return over the past 5 years, yet its current valuation still screens as cheap. An intrinsic value estimate from a Discounted Cash Flow (DCF) model suggests the shares trade at a meaningful discount to that estimate, while market multiples also lean toward an undervalued verdict. A 167.1% total return over 5 years sets a high bar for Cencora. Any hint that cash flow growth slows or that returns on capital plateau may make the current valuation...",
                "category": "company",
                "datetime": 1785006547,
                "headline": "Cencora (COR) Stock Looks Undervalued As Its 167% Five Year Return Builds"
              },
              {
                "id": 141007898,
                "url": "https://finnhub.io/api/news?id=4e1b2df29b10a81eb5b7242e1dd9bf833179ad3e79e293a12a1feb8308f4a946",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "HCA tops Q2 EPS estimates on higher admissions and revenue per admission but trims parts of its 2026 guidance as higher expenses and weaker surgical volumes weigh on results.",
                "category": "company",
                "datetime": 1784908020,
                "headline": "HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised"
              },
              {
                "id": 141007920,
                "url": "https://finnhub.io/api/news?id=87f8d85494584027365a3886769e86bfba2dbfdaab5bcc5ff6b64728ff179ba8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.",
                "category": "company",
                "datetime": 1784905740,
                "headline": "Here's Why You Should Add Cencora Stock to Your Portfolio Now"
              },
              {
                "id": 141012810,
                "url": "https://finnhub.io/api/news?id=dce0ba84fa1c759c33f7936450c66e2227246ddf1d6e9033c7db2dc808d0e1bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the July 22nd & 23rd Precious Metals & Critical Minerals Virtual Investor Conference are available for on-demand viewing. REGISTER AND VIEW PRESENTATIONS HERE Select companies are accepting 1x1 management meeting requests through July 28th. Ple",
                "category": "company",
                "datetime": 1784896500,
                "headline": "Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing"
              },
              {
                "id": 141005404,
                "url": "https://finnhub.io/api/news?id=8a384b45620c13a87e12e317eb5f57ee9ee7d599c1e14287ef3165cb122484fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "AIM, HAS, FOX, COR and ISRG make the list of stocks with rising P/E ratios, a screen highlighting companies investors may view as having stronger earnings potential.",
                "category": "company",
                "datetime": 1784894640,
                "headline": "Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical"
              },
              {
                "id": 140997787,
                "url": "https://finnhub.io/api/news?id=62fce0608d45e410c0de9b5328f24b3e6e5af974a2273c77868794b05275e66a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.",
                "category": "company",
                "datetime": 1784830020,
                "headline": "MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised"
              },
              {
                "id": 140993531,
                "url": "https://finnhub.io/api/news?id=c1a514d34892603e11a490f386652a4c3bd465e5c5eac00d776ac1af9ad68ca9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "COR",
                "summary": "Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.",
                "category": "company",
                "datetime": 1784809500,
                "headline": "Bet on 5 Top-Ranked Stocks With Rising P/E"
              },
              {
                "id": 140984451,
                "url": "https://finnhub.io/api/news?id=40377394e5eac1329685378fc50aa7962b376877c95d00beb129e0e4133a896d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2254790504/image_2254790504.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "COR",
                "summary": "Cencora (COR) shifts to specialty pharma infrastructure, boosting margins via acquisitions and raising FY2026 EPS guidance.",
                "category": "company",
                "datetime": 1784727714,
                "headline": "Cencora: Specialty Infrastructure Is Rewriting The Distributor Model"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 71,
            "discarded_article_count": 56
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 16.6,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.9,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日2日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1552243.3333333333,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1943660,
              "avg_vol_20": 1510980,
              "avg_vol_30": 1552243.3333333333,
              "range_pct_10": 0.10469394938085953,
              "range_pct_20": 0.11365315329728362,
              "range_pct_30": 0.13262729977922127,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.2521619247841298,
              "dist_to_20d_high": 0.064141366547646,
              "down_shrink_days": 1,
              "breakout_level_20d": 333.95001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7893846105224103
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.1947653025309575,
              "turnoverUsdM": 205.44065791,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.COR",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 292.5608,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.4,
            "take_profit_price": 328.1565,
            "target_multiplier": 1.6,
            "technical_strength": 1.22,
            "take_profit_percent": 5
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.389530605061915,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 9.9846,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.19
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 3.83
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0677
    },
    "kdj": {
      "d": 54.27,
      "j": 22.36,
      "k": 43.63,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 50.05
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 7087353,
      "recentSlope": 329345.3,
      "previousSlope": -376250
    },
    "rsi": 45.54,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 330.7381,
      "position": "SAR喺價上",
      "distancePct": 5.83,
      "previousTrend": "下降"
    },
    "ma50": 299.3198,
    "macd": {
      "macd": 4.855565909900349,
      "trend": "中性偏多",
      "signal": 6.358352848972936,
      "histogram": -1.5027869390725872
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 314.4295,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.44,
      "score": 2,
      "avgVolume": 1482307,
      "currentVolume": 657347
    },
    "derived": {
      "ma20": 313.9125,
      "ma50": 299.3198,
      "prevClose": 313.82,
      "avgVolume10": 1849105,
      "avgVolume20": 1482307,
      "changePercent": -0.41,
      "avgVolumeForScore": 1482307
    },
    "ma_cross": {
      "ma20": 313.9125,
      "ma50": 299.3198,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 313.4855,
      "prevMa50": 298.4756,
      "spreadPct": 4.88,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 298.0033,
      "upper": 329.8217,
      "position": "中間"
    },
    "rsi_short": 40.64,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.44
    }
  }
}

{
  "close": 312.53,
  "volume": 657347,
  "changePercent": -0.41
}